Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome

被引:18
作者
Berney, D. M.
Fisher, G.
Kattan, M. W.
Oliver, R. T. D.
Moller, H.
Fearn, P.
Eastham, J.
Scardino, P.
Cuzick, J.
Reuter, V. E.
Foster, C. S.
机构
[1] St Bartholomews Hosp, Dept Histopathol, London EC1A 7BE, England
[2] Wolfson Inst Prevent Med, Canc Res UK, Ctr Epidemiol Math & Stat, London, England
[3] Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH USA
[4] Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[6] Univ Liverpool, Dept Cellular Pathol & Mol Genet, Liverpool L69 3BX, Merseyside, England
基金
英国医学研究理事会;
关键词
atypical adenomatous hyperplasia; biopsy; error; prostate;
D O I
10.1111/j.1365-2559.2007.02819.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: To assess the possible reasons for error in the diagnosis of prostatic cancer with available follow-up data. Method and results: A cohort of 1791 cases of prostatic cancer diagnosed in the UK between 1990 and 1996 was examined. All cases were clinically localized at presentation, treated by non-curative methods and detailed follow-up was available. A panel of genitourinary pathologists reviewed the pathology of all cases. One hundred and thirty-three (7.5%) of cases were reassigned to a non-malignant diagnosis. Where possible, reasons for the initial diagnosis were given. These included severe atrophy, inflammatory induced atypia, sclerosing adenosis, atypical adenomatous hyperplasia and basal cell hyperplasia. Follow-up of these patients showed an extremely low death rate from prostatic cancer: lower than that for the Gleason combined score of five or less tumours diagnosed in this series. Conclusions: Many morphological entities potentially mimic prostatic cancer and may be responsible for misdiagnosis in routine specimens. Continuing education in prostatic morphology and immunohistochemistry may have helped reduce this error rate.
引用
收藏
页码:452 / 457
页数:6
相关论文
共 24 条
[1]   Variations in the processing of prostatic needle cores in the UK; what is safe? [J].
Biedrzycki, O ;
Varma, M ;
Berney, DM .
JOURNAL OF CLINICAL PATHOLOGY, 2003, 56 (05) :341-343
[2]  
Bostwick D G, 1999, Semin Urol Oncol, V17, P199
[3]  
Brawer M K, 1999, Semin Urol Oncol, V17, P206
[4]   Long-term outcome among men with conservatively treated localised prostate cancer [J].
Cuzick, J. ;
Fisher, G. ;
Kattan, M. W. ;
Berney, D. ;
Oliver, T. ;
Foster, C. S. ;
Moller, H. ;
Reuter, V. ;
Fearn, P. ;
Eastham, J. ;
Scardino, P. .
BRITISH JOURNAL OF CANCER, 2006, 95 (09) :1186-1194
[5]  
Davis LD, 2002, ANTICANCER RES, V22, P3819
[6]  
DODSON AR, 2005, RECENT ADV HISTOPATH, P105
[7]   Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol [J].
Durkan, GC ;
Sheikh, N ;
Johnson, P ;
Hildreth, AJ ;
Greene, DR .
BJU INTERNATIONAL, 2002, 89 (01) :33-39
[8]   Clinical and cost impact of second-opinion pathology - Review of prostate biopsies prior to radical prostatectomy [J].
Epstein, JI ;
Walsh, PC ;
Sanfilippo, F .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (07) :851-857
[9]  
FOSTER CS, 2001, DURR DIAGN PATH, V7, P194
[10]  
Gaudin P B, 1997, Anat Pathol, V2, P111